Literature DB >> 27009790

Pyoderma Gangrenosum: A Report of 27 Patients.

Esra Adışen1, Funda Erduran2, Mehmet Ali Gürer2.   

Abstract

The aim of this study was to document the profile of pyoderma gangrenosum (PG) patients who were treated in our clinic and to compare our patients' clinical and demographic characteristics with those described in the literature to help our understanding of the total burden of PG. A total of 27 (17 women, 10 men) patients with a mean age 48.6 years at diagnosis were included in the study. Seven (25.9%) of them had 3 or more ulcers. The lower extremity was the most common site of occurrence (92.5%). During the study period, 6 patients were admitted twice, and 7 were admitted 3 or more times (range 1 to >10), and the median length of stay was 27 days. A concomitant disease was present in PG patients especially in those between 20 and 40 years of age. Systemic therapy was used in 21 (91.3%) patients, 17 patients were treated with systemic corticosteroids, either alone in 7 patients or combination with other agents in 10 patients. Three of our patients died because of disease or treatment-related complications during the study period. Despite the high (70.3%) percentage of the PG patients with improving disease at the time of discharge, 1 year after hospital discharge, one third of our 27 patients still had PG requiring readmission. In conclusion, none of the current therapies provide satisfying results in all of the patients, and our data indicate a long-standing unmet need for effective therapy for the unexpected course of PG.
© The Author(s) 2016.

Entities:  

Keywords:  cutaneous ulcers; pyoderma gangrenosum; treatment

Mesh:

Substances:

Year:  2016        PMID: 27009790     DOI: 10.1177/1534734616639172

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  6 in total

1.  Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study.

Authors:  Khalaf Kridin; Giovanni Damiani; Arnon D Cohen
Journal:  Clin Rheumatol       Date:  2020-07-01       Impact factor: 2.980

2.  Pyoderma gangrenosum mimicking inflammatory breast cancer.

Authors:  Agnieszka Białecka; Kaja Męcińska-Jundziłł; Urszula Adamska; Magdalena Górecka-Sokołowska; Artur Czaplewski; Aleksandra Grzanka; Marcin Białecki; Katarzyna Nadolska; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

3.  Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid.

Authors:  William J Nahm; Jorge A Mota; Sarah Rojas; Brian J Hizon; Chris Gordon
Journal:  Am J Case Rep       Date:  2018-07-19

4.  Recalcitrant Ulcerative Pyoderma Gangrenosum of the Leg Responsive to Tildrakizumab: A Case Report.

Authors:  Liang Joo Leow; Nicolas Zubrzycki
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-23

5.  Clinical and histological patterns and treatment of pyoderma gangrenosum.

Authors:  Radia Chakiri; Hanane Baybay; Asmae El Hatimi; Salim Gallouj; Taoufiq Harmouch; Fatima Zohra Mernissi
Journal:  Pan Afr Med J       Date:  2020-06-02

Review 6.  Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature.

Authors:  Aleksandra Opalińska; Dominika Kwiatkowska; Adrian Burdacki; Mirosław Markiewicz; Dominik Samotij; Marek Dudziński; Jadwiga Niemiec-Dudek; Elżbieta Ostańska; Adam Reich
Journal:  Dermatol Ther (Heidelb)       Date:  2021-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.